Cetera Investment Advisers Acquires 43,505 Shares of Amrize Ltd $AMRZ

Key Points

• Cetera Investment Advisers increased its Amrize stake by 408.1% in the first quarter, purchasing 43,505 shares for a total holding of 54,165 shares valued at approximately $3.03 million.
• Amrize insiders bought 54,918 shares worth about $2.72 million over the past 90 days, including purchases by CTO Roald Brouwer and insider Mario Gross.
• Analysts maintain a consensus “Moderate Buy” rating with a $62.79 price target, although several firms recently lowered their targets. Amrize’s latest quarter showed revenue growth and higher net income, but EPS of $0.88 missed the $0.92 consensus estimate.

Cetera Investment Advisers grew its stake in Amrize Ltd (NYSE:AMRZ - Free Report) by 408.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 54,165 shares of the company's stock after buying an additional 43,505 shares during the period. Cetera Investment Advisers' holdings in Amrize were worth $3,034,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. MCF Advisors LLC bought a new stake in shares of Amrize during the 4th quarter worth $27,000. Basepoint Wealth LLC acquired a new position in Amrize during the 4th quarter worth $33,000. Laurel Wealth Advisors LLC bought a new stake in Amrize during the fourth quarter valued at about $34,000. US Bancorp DE bought a new stake in Amrize during the third quarter valued at about $38,000. Finally, Itau Unibanco Holding S.A. grew its position in shares of Amrize by 150.0% in the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company's stock valued at $41,000 after purchasing an additional 450 shares during the last quarter.

Insider Buying and Selling at Amrize

In other Amrize news, CTO Roald Brouwer bought 1,500 shares of the stock in a transaction that occurred on Thursday, May 21st. The shares were acquired at an average price of $49.84 per share, with a total value of $74,760.00. Following the completion of the purchase, the chief technology officer directly owned 19,757 shares in the company, valued at $984,688.88. The trade was a 8.22% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Mario Gross bought 1,200 shares of the business's stock in a transaction that occurred on Wednesday, May 20th. The shares were bought at an average price of $48.63 per share, with a total value of $58,356.00. Following the transaction, the insider directly owned 34,747 shares in the company, valued at $1,689,746.61. This trade represents a 3.58% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired a total of 54,918 shares of company stock valued at $2,717,324 in the last 90 days. Insiders own 0.54% of the company's stock.

Analysts Set New Price Targets

Several research firms recently weighed in on AMRZ. Wells Fargo & Company cut their price objective on Amrize from $65.00 to $58.00 and set an "overweight" rating for the company in a research report on Wednesday, July 8th. Citigroup dropped their price target on Amrize from $76.00 to $66.00 and set a "buy" rating on the stock in a research report on Monday, May 4th. Stephens reissued an "overweight" rating and issued a $65.00 price objective on shares of Amrize in a research report on Monday, May 18th. Truist Financial restated a "hold" rating and issued a $48.00 price objective (down from $65.00) on shares of Amrize in a research note on Tuesday, July 7th. Finally, Sanford C. Bernstein reaffirmed an "outperform" rating on shares of Amrize in a research report on Monday, June 22nd. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $62.79.

More Amrize News

Here are the key news stories impacting Amrize this week:

• Positive Sentiment: Amrize reported second-quarter revenue of $3.49 billion, an 8.6% year-over-year increase, supported by demand from data centers, energy projects, advanced manufacturing and infrastructure modernization. Building Materials revenue rose 8.2%, while Building Envelope revenue increased 9.4%. Amrize Reports Second Quarter 2026 Results
• Positive Sentiment: Net income grew 14.4% to $476 million, compared with $416 million a year earlier. The company also returned $502 million to shareholders through $197 million in share repurchases and $305 million in dividends. Amrize Q2 revenue rises 8.6% to $3.49 billion
• Positive Sentiment: Management raised its 2026 revenue outlook to $12.5 billion-$12.7 billion, above the roughly $12.4 billion analyst consensus, and set adjusted EBITDA guidance at $3.1 billion-$3.2 billion. The improved outlook signals continued confidence in project demand despite inflationary pressures. Amrize Lifts 2026 Revenue Outlook as Q2 Profits Surge Despite Cost Pressure
• Neutral Sentiment: Amrize declared a quarterly dividend of $0.11 per share, payable August 26, 2026. Several company insiders also reportedly bought shares during the past six months, a potential confidence signal but not a direct earnings catalyst. Amrize Q2 revenue rises 8.6% to $3.49 billion
• Negative Sentiment: Reported EPS of $0.88 fell short of the $0.92 consensus estimate. Although earnings improved from $0.78 a year earlier, the miss likely drove the initial investor reaction, particularly as higher fuel, freight and other costs constrained adjusted EBITDA growth and margins. Amrize Ltd Misses Q2 Earnings Estimates

Amrize Stock Performance

Shares of NYSE AMRZ opened at $51.23 on Friday. The firm has a market capitalization of $28.33 billion, a price-to-earnings ratio of 24.51, a PEG ratio of 1.12 and a beta of 0.11. Amrize Ltd has a one year low of $44.12 and a one year high of $65.94. The business has a fifty day simple moving average of $52.09 and a 200 day simple moving average of $54.78. The company has a current ratio of 1.40, a quick ratio of 0.89 and a debt-to-equity ratio of 0.38.

Amrize (NYSE:AMRZ - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). Amrize had a return on equity of 9.84% and a net margin of 9.70%. Sell-side analysts expect that Amrize Ltd will post 2.76 EPS for the current year.

Amrize Cuts Dividend

The firm also recently announced a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, May 12th. Amrize's payout ratio is 21.05%.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source